ROBICHAUD ALBERT (Chief Scientific Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/21/2021ACC: 0001562180-21-006599
Officer· Chief Scientific Officer
Since Dec 2018
+2.68K
Net shares
Net buyer
$45.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
3.80K acquired · 1.12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.80K
Price / share
—
Trade value
—
% of position
2.7%
10/19/2021
139.94K→143.74K
Common Stock
Direct
Shares
−1.12K
Price / share
$40.29
Trade value
$44.96K
% of position
0.8%
10/19/2021
143.74K→142.62K
Total
Net shares
+2.68K
Net value
-$44.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/19/2021 | A · Award | +3.80K | — | — | 2.7% | 139.94K | 143.74K |
| Common Stock Direct | 10/19/2021 | F · Tax Withholding | −1.12K | $40.29 | $44.96K | 0.8% | 143.74K | 142.62K |
| Total | +2.68K | -$44.96K | ||||||
Derivative Transactions0
No derivative transactions reported